shutterstock_446090386_cristian_gusa
Cristian Gusa / Shutterstock.com
30 January 2024BiotechnologyMarisa Woutersen

Force pharma companies to provide drugs for rare cancer trials, UK govt told

MHRA 'should regulate' the release of drugs for clinical trials for innovative cancer treatments | Medical experts lambast big pharma’s unacceptable lack of involvement in Glioblastoma campaign | Forcing companies will ‘undermine public trust’ says pharma body.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
7 December 2023   Case dismissed with settlement between Novartis and Daiichi Sankyo unit | Melanoma therapy at centre of feud after Novartis faced infringement claims over Tafinlar.
Americas
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.

More on this story

Big Pharma
7 December 2023   Case dismissed with settlement between Novartis and Daiichi Sankyo unit | Melanoma therapy at centre of feud after Novartis faced infringement claims over Tafinlar.
Americas
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.

More on this story

Big Pharma
7 December 2023   Case dismissed with settlement between Novartis and Daiichi Sankyo unit | Melanoma therapy at centre of feud after Novartis faced infringement claims over Tafinlar.
Americas
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.